Researching ME/CFS: priority area
UK Research and Innovation funds research into ME/CFS biology, diagnostics, and treatments, with a focus on collaboration, multidisciplinary science, and patient involvement.
Funder: UK Research and Innovation
Due Dates: Rolling (no closing date)
Funding Amounts: Typically up to 80% of full economic cost; award size and duration depend on the selected MRC scheme.
Summary: Supports innovative research addressing top priorities in ME/CFS, including biological mechanisms, diagnostics, and treatments, with a focus on collaboration and patient involvement.
Description
This opportunity supports research into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through any Medical Research Council (MRC) funding scheme under UK Research and Innovation (UKRI). The aim is to encourage high-quality, multidisciplinary research that addresses the key scientific questions and priorities identified by the ME/CFS Priority Setting Partnership. Priority areas include understanding post-exertional malaise, developing diagnostics, investigating immune and genetic factors, exploring neurological and mitochondrial dysfunction, and identifying effective treatments. The program emphasizes building research capacity, fostering collaboration—including international and cross-disciplinary partnerships—and involving people living with ME/CFS throughout the research process.
